CytoMed Therapeutics Ltd

NASDAQ:GDTC

2.00

0.00 (+0.10%)

4:10:04 PM EDT: $2.04 +0.04 (+1.90%)

CytoMed Therapeutics Ltd Stock, NASDAQ:GDTC

1 Commonwealth Lane, No. 08-22, One Commonwealth, Singapore, Central Singapore 149544

Singapore

Phone: +65.6250.7738

Number of Employees: 34

http://www.cytomed.sg

Description

CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.